Table 1.
Estimates of general population HBsAg prevalence, and number of HBsAg positive people in the general population, by country, Europe, 2000-2009
| Country* (Reference) | Period | Area | Region | Sampling | N | % | (95% CI)** | Remarks | Population size [36] | Number of HBsAg-positive inhabitants |
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium [91] |
2003 |
regional |
Flanders |
random |
1.834 |
0,7 |
(0,5-0,8) & |
Oral fluid |
10.754.528 |
75.282 |
| Czech Republic [92] |
2001 |
nationwide |
- |
random |
2.658 |
0,6 |
(0,3-1,0) $ |
Standardized |
10.467.542 |
62.805 |
| Finland [93] |
1997-1998 |
nationwide |
- |
residual |
3.083 |
0,2 |
(0,1-0,4) $ |
|
5.326.314 |
10.653 |
| Germany [94] |
1993-1996 |
nationwide |
- |
random |
5.305 |
0,6 |
(0,4-0,8) & |
|
82.050.000 |
492.300 |
| Germany [95] |
1998 |
nationwide |
- |
random |
6.748 |
0,6 |
(0,4-0,8) & |
|
|
|
| Greece [96] |
1997-1998 |
regional |
Peloponnesos |
random |
1.500 |
2,1 |
(1,5-3,0) & |
|
11.257.285 |
236.403 |
| Ireland [93] |
2003 |
nationwide |
- |
residual |
2.535 |
0,1 |
(0,0-0,3) $ |
|
4.465.540 |
4.466 |
| Italy [93] |
1996 |
nationwide |
- |
residual |
3.522 |
0,6 |
(0,4-1,0) $ |
|
60.053.442 |
840.748 |
| Italy [74] |
2002 |
regional |
North |
convenience |
956 |
1,0 |
(0,5-1,9) $ |
|
|
|
| Italy [97] |
1997 |
regional |
Central |
random |
250 |
1,2 |
(0,3-3,5) $ |
|
|
|
| Italy [98] |
1997 |
regional |
South |
random |
488 |
0,2 |
(0,0-3,5) $ |
|
|
|
| Italy [99] |
2002-2003 |
regional |
South |
random |
1.645 |
1,8 |
(0,4-1,2) & |
|
|
|
| Italy [100] |
1994-1994 |
regional |
Sardinia |
convenience |
3.324 |
4,3 |
(3,6-5,1) $ |
|
|
|
| Italy [101] |
1999-2000 |
regional |
Sicily |
random |
721 |
0,7 |
(0,2-1,6) $ |
|
|
|
| Netherlands [93] |
1995-1996 |
nationwide |
- |
random |
6.750 |
0,1 |
(0,0-0,2) $ |
|
16.486.587 |
16.487 |
| Romania [93] |
2002 |
nationwide |
- |
residual |
1.259 |
5,6 |
(4,4-7,0) $ |
|
21.498.616 |
1.203.922 |
| Slovakia [93] |
2002 |
nationwide |
- |
random |
3.569 |
0,6 |
(0,4-0,9) $ |
|
5.412.254 |
32.474 |
| Spain [102] |
1996 |
regional |
Catalonia |
random |
2.142 |
1,2 |
(0,7-1,7) & |
Standardized |
45.828.172 |
458.282 |
| Spain [103] |
2002 |
regional |
Catalonia |
random |
2.620 |
0,7 |
(0,4-1,0) & |
|
|
|
| Sweden [104] |
1991-1994 |
regional |
Malmö |
random |
5.533 |
0,2 |
(0,1-0,4) $ |
|
9.256.347 |
18.513 |
| Turkey [105] |
2006-2007 |
regional |
West |
random |
2.852 |
2,5 |
(2,0-3,1) $ |
|
71.517.100 |
3.718.889 |
| Turkey [106] |
2002-2004 |
regional |
Central |
convenience |
1.320 |
6,6 |
(5,3-8,1) $ |
|
|
|
| Turkey [107] |
1996 |
regional |
Central |
convenience |
571 |
6,7 |
(4,8-9,1) $ |
|
|
|
| Turkey [108] |
Not reported |
regional |
Central |
random |
1.095 |
5,5 |
(4,2-7,0) $ |
|
|
|
| Turkey [109] |
1997-1999 |
regional |
East |
convenience |
400 |
9,0 |
(6,4-12,2) $ |
32-year-olds |
|
|
| Turkey [110] | 2003 | regional | East | random | 2.888 | 7,0 | (6,1-8,0) $ |
* No estimate of HBsAg general population prevalence was found for Austria, Bulgaria, Croatia, Denmark, Estonia, Former Yugoslav Republic of Macedonia, France, Hungary, Iceland, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovenia, Switzerland and the United Kingdom.
** CI Confidence interval.
& CI provided in the original paper.
$ CI estimated by the exact method.